retatrutide phase 2 trial obesity triple agonist hormone receptor for metabolic dysfunction-associated steatotic liver disease: a randomized 2a Lilly's triple agonist, retatrutide, delivered
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1























